Sustainable Development Report and Environmental, Social and Governance Report

Overview

The report describes Shanghai Pharmaceuticals' Board-led ESG governance and a broad 2021 sustainability program spanning product quality, employee development, medical accessibility, environmental protection and public welfare. It highlights 71 technical renovation projects, no environmental penalties, and RMB44.97mm in charitable donations. The report also provides extensive group sustainability disclosures covering employees, occupational health, energy, emissions, waste, supply chains and community investment.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2021
Period: 1 January 2021 – 31 December 2021
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services